Clinical Trials Directory

Trials / Unknown

UnknownNCT06010927

Effect of Ketamine/Midazolam Premedication Versus Pre-extubation Ketofol on Recovery Profile in Pediatrics Undergoing Adenotonsillectomy.

Ketamine/Midazolam Premedication Versus Pre-extubation Ketofol. Effect on Emergence Agitation and Recovery Profile After Pediatric Adenotonsillectomy: A Randomized Comparative Study.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
3 Years – 10 Years
Healthy volunteers
Not accepted

Summary

An optimum recovery profile after AT includes a rapid, smooth awakening without emergence agitation (EA), stable vital signs and oxygenation, reduced postoperative nausea and vomiting (PONV), controlled postoperative pain, and patient or parents' satisfaction. Ketamine is a low-cost drug with a wide therapeutic window. Ketamine is a competitive N-methyl-D-aspartate receptor antagonist with good analgesic properties and periprocedural amnesia. The ketamine/midazolam combination was administered in different ways with controversial results about their effect on the EA and recovery profile. Ketofol, a mixture of ketamine and propofol, has been used in different favorable recovery profiles regarding postoperative EA and PONV. This study aims to evaluate the effect of premedication with an intramuscular ketamine/ midazolam combination versus pre-extubation ketofol on the EA and the recovery profile.

Conditions

Interventions

TypeNameDescription
DRUGketamine/midazolampremedication
DRUGKetofolPre-extubation

Timeline

Start date
2023-08-25
Primary completion
2023-11-01
Completion
2023-12-01
First posted
2023-08-25
Last updated
2023-09-15

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06010927. Inclusion in this directory is not an endorsement.